Vigabatrin

3 trials 3 recruiting NNeurology/Psychiatry

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

3 Recruiting

0 Completed trials

3 Sponsors

4 Countries

Phase II/III

Phase II

Phase IV

Phase II/III: 1 Phase II: 1 Phase IV: 1

Sponsors using this IMP

Heidelberg University Hospital AöR 1 HUS-Yhtymae 1 Instytut Pomnik Centrum Zdrowia Dziecka 1

All trials

3 total

Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months … Recruiting

2022-502332-39-00 Phase II 2 countries Heidelberg University Hospital AöR
Comparison of the efficacy and safety of rapamycin versus vigabatrin in the prevention of Tuberous Sclerosis Complex symptoms in infants in … Recruiting

2024-513068-25-00 Phase II/III 1 country Instytut Pomnik Centrum Zdrowia Dziecka
Prediction and prevention of infantile spasms in high risk children Recruiting

2024-517488-22-00 Phase IV 1 country HUS-Yhtymae

Showing 1–3 of 3 trials

← All drugs A–Z